Osteosarcoma cells induce endothelial cell proliferation during neo-angiogenesis

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Tumor microenvironment stimuli can induce endothelial cell (EC) proliferation, a key process in angiogenesis.
• Understanding these mechanisms is crucial for developing effective antiangiogenic therapies.

Purpose of the Study:

• To investigate the role of cyclin-dependent kinases 2 and 5 (Cdk2, Cdk5) in tumor-induced EC proliferation and angiogenesis.
• To evaluate the potential of Cdk inhibitors as antiangiogenic and antitumor agents.

Main Methods:

• In vitro and in vivo models using human aortic endothelial cells (HAECs) and osteosarcoma (SaOS) cells.
• Analysis of Cdk2 and Cdk5 expression and activity.
• Assessment of EC proliferation and capillary-like structure formation.
• Treatment with Roscovitine, a Cdk inhibitor, and evaluation of its effects on ECs and SaOS cells.

Main Results:

• Osteosarcoma cells secrete a Yin Yang 1 (YY1)-dependent signal that promotes HAEC proliferation, Cdk2/Cdk5 overexpression, and increased Cdk2 activity.
• Roscovitine inhibited Cdk2/Cdk5 overexpression and activity, significantly reducing HAEC proliferation and angiogenesis (70% in vitro, 50% in vivo).
• Roscovitine induced apoptosis in both SaOS and HAEC cells via caspase-3/7 activation.

Conclusions:

• Cdk2 and Cdk5 are critical mediators of tumor-induced angiogenesis.
• Roscovitine demonstrates significant antiangiogenic and antitumor potential by inhibiting Cdk activity and inducing apoptosis.
• Cdk2 and Cdk5 represent promising therapeutic targets for antiangiogenic and antitumor strategies.